174 related articles for article (PubMed ID: 23599147)
21. Molecular diagnostic algorithm for epidermal growth factor receptor mutation detection in Asian lung adenocarcinomas: comprehensive analyses of 445 Taiwanese patients with immunohistochemistry, PCR-direct sequencing and Scorpion/ARMS methods.
Ho HL; Chang FP; Ma HH; Liao LR; Chuang YT; Chang-Chien YC; Lin KY; Chou TY
Respirology; 2013 Nov; 18(8):1261-70. PubMed ID: 23796143
[TBL] [Abstract][Full Text] [Related]
22. Successful lung cancer EGFR sequencing from DNA extracted from TTF-1 immunohistochemistry slides: a new means to extend insufficient tissue.
Deftereos G; Sandoval A; Furtado LV; Bronner M; Matynia AP
Hum Pathol; 2020 Mar; 97():52-59. PubMed ID: 31978505
[TBL] [Abstract][Full Text] [Related]
23. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.
Bhargava R; Gerald WL; Li AR; Pan Q; Lal P; Ladanyi M; Chen B
Mod Pathol; 2005 Aug; 18(8):1027-33. PubMed ID: 15920544
[TBL] [Abstract][Full Text] [Related]
24. PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
Kim S; Koh J; Kim MY; Kwon D; Go H; Kim YA; Jeon YK; Chung DH
Hum Pathol; 2016 Dec; 58():7-14. PubMed ID: 27473266
[TBL] [Abstract][Full Text] [Related]
25. The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma.
Kozu Y; Tsuta K; Kohno T; Sekine I; Yoshida A; Watanabe S; Tamura T; Yokota J; Suzuki K; Asamura H; Furuta K; Tsuda H
Lung Cancer; 2011 Jul; 73(1):45-50. PubMed ID: 21129809
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.
Allo G; Bandarchi B; Yanagawa N; Wang A; Shih W; Xu J; Dalby M; Nitta H; To C; Liu N; Sykes J; Tsao MS
Histopathology; 2014 May; 64(6):826-39. PubMed ID: 24251405
[TBL] [Abstract][Full Text] [Related]
27. Detecting EGFR alterations in clinical specimens-pitfalls and necessities.
Isaksson S; Bendahl PO; Salomonsson A; Jönsson M; Haglund M; Gaber A; Jirström K; Jönsson P; Borg A; Johansson L; Staaf J; Planck M
Virchows Arch; 2013 Dec; 463(6):755-64. PubMed ID: 24158511
[TBL] [Abstract][Full Text] [Related]
28. High EGFR gene copy number predicts poor outcome in triple-negative breast cancer.
Park HS; Jang MH; Kim EJ; Kim HJ; Lee HJ; Kim YJ; Kim JH; Kang E; Kim SW; Kim IA; Park SY
Mod Pathol; 2014 Sep; 27(9):1212-22. PubMed ID: 24406864
[TBL] [Abstract][Full Text] [Related]
29. EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
Thomas De Montpréville V; Ghigna MR; Lacroix L; Lemoine A; Besse B; Mercier O; Fadel É; Dorfmuller P; Le Chevalier T;
Pathol Res Pract; 2017 Jul; 213(7):793-798. PubMed ID: 28554746
[TBL] [Abstract][Full Text] [Related]
30. Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma.
Mackinnon AC; Luevano A; de Araujo LC; Rao N; Le M; Suster S
Mod Pathol; 2014 Aug; 27(8):1063-72. PubMed ID: 24390215
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
[TBL] [Abstract][Full Text] [Related]
32. Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.
Wang J; Andrici J; Sioson L; Clarkson A; Sheen A; Farzin M; Toon CW; Turchini J; Gill AJ
Hum Pathol; 2016 Sep; 55():83-90. PubMed ID: 27184481
[TBL] [Abstract][Full Text] [Related]
33. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
34. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
[TBL] [Abstract][Full Text] [Related]
35. [Mutation-specific antibodies for detection of epidermal growth factor receptor mutations in patients with lung adenocarcinoma].
Zhang Q; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):168-72. PubMed ID: 23769435
[TBL] [Abstract][Full Text] [Related]
36. Diamond: immunohistochemistry versus sequencing in EGFR analysis of lung adenocarcinomas.
Ragazzi M; Tamagnini I; Bisagni A; Cavazza A; Pagano M; Baldi L; Boni C; Cantile F; Barbieri F; Nicoli D; Sartori G; de Biase D; Gardini G; Rossi G
J Clin Pathol; 2016 May; 69(5):440-7. PubMed ID: 26553934
[TBL] [Abstract][Full Text] [Related]
37. Epidermal Growth Factor Receptor Gene Mutation in Pleural Lavage Cytology Findings of Primary Lung Adenocarcinoma Cases.
Inoue T; Matsumura Y; Araki O; Karube Y; Maeda S; Kobayashi S; Chida M
Ann Thorac Cardiovasc Surg; 2018 Feb; 24(1):1-5. PubMed ID: 29093430
[TBL] [Abstract][Full Text] [Related]
38. EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing.
Ambrosini-Spaltro A; Campanini N; Bortesi B; Azzoni C; Naldi N; Ampollini L; Tiseo M; Ardizzoni A; Rusca M; Carbognani P; Silini EM
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):356-62. PubMed ID: 22710815
[TBL] [Abstract][Full Text] [Related]
39. High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.
Thomas A; Chen Y; Steinberg SM; Luo J; Pack S; Raffeld M; Abdullaev Z; Alewine C; Rajan A; Giaccone G; Pastan I; Miettinen M; Hassan R
Oncotarget; 2015 May; 6(13):11694-703. PubMed ID: 26028668
[TBL] [Abstract][Full Text] [Related]
40. EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma.
Chalela R; González-García JG; Khilzi K; Curull V; Sánchez-Font A; Longarón R; Rodrigo-Calvo MT; Martín-Ontiyuelo C; Gea J; Bellosillo B
Pathol Oncol Res; 2021; 27():598292. PubMed ID: 34257550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
